Neuroscience

Targeting tau, the other protein behind Alzheimer's disease

In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...

Alzheimer's disease & dementia

Alzheimer's and daytime napping linked in new research

Could there be a link between cognitive decline and excessive daytime napping? New research from the Rush Alzheimer's Disease Center suggests a potential connection, according to an article published in Alzheimer's and Dementia: ...

page 2 from 14